SHERMAN JEFFREY W
Insider CIK 1230482 · XERS Director · LRMR Director · HZNP EVP, Chief Medical Officer · SBBP Director · XERS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2026-05-19 | 2026-05-20 | 55,150 | — | $0 | 55,150 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2026-02-27 | 2026-03-02 | 5,000 | $5.00 | $25.0K | 5,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise deriv | 2025-08-28 | 2025-08-29 | 47,040 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2025-08-28 | 2025-08-29 | 42,232 | $7.92 | $334.5K | 219,188 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise | 2025-08-28 | 2025-08-29 | 47,040 | $6.66 | $313.3K | 261,420 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2025-06-04 | 2025-06-04 | 50,000 | — | $0 | 214,380 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2025-05-13 | 2025-05-14 | 19,000 | — | $0 | 19,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2024-06-05 | 2024-06-05 | 50,000 | — | $0 | 164,380 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2024-05-29 | 2024-05-31 | 19,000 | — | $0 | 19,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | J Other | 2024-03-15 | 2024-04-11 | 6,502 | — | $0 | 114,380 | SEC↗ |
| XERS Xeris Biopharma Holdings, | P Buy | 2023-11-27 | 2023-11-29 | 5,400 | $1.87 | $10.1K | 5,400 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 18,397 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 4,599 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 4,599 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 9,200 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 11,426 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 12,696 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 19,044 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 12,226 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 4,654 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 27,942 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 164,469 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 9,314 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 3,809 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer | 2023-10-06 | 2023-10-06 | 2,655 | $116.50 | $309.3K | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer | 2023-10-06 | 2023-10-06 | 105,808 | $116.50 | $12.33M | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer | 2023-10-06 | 2023-10-06 | 80,944 | $116.50 | $9.43M | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer | 2023-10-06 | 2023-10-06 | 45,352 | $116.50 | $5.28M | 0 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2023-10-03 | 2023-10-05 | 16,600 | — | $0 | 16,600 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2023-09-06 | 2023-09-07 | 2,165 | — | $0 | 80,944 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2023-06-07 | 2023-06-07 | 42,500 | — | $0 | 107,878 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2023-01-17 | 2023-01-18 | 33,795 | — | $0 | 2,376 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2023-01-17 | 2023-01-18 | 33,795 | — | $0 | 83,109 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2023-01-11 | 2023-01-12 | 3,368 | $113.10 | $380.9K | 36,171 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2023-01-10 | 2023-01-12 | 3,368 | $113.05 | $380.8K | 39,539 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2023-01-06 | 2023-01-06 | 5,187 | $113.29 | $587.6K | 49,314 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2023-01-05 | 2023-01-06 | 12,095 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2023-01-05 | 2023-01-06 | 9,314 | — | $0 | 9,314 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2023-01-05 | 2023-01-06 | 6,348 | — | $0 | 12,696 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2023-01-05 | 2023-01-06 | 7,257 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2023-01-05 | 2023-01-06 | 1,966 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2023-01-05 | 2023-01-06 | 9,318 | — | $0 | 4,654 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2023-01-05 | 2023-01-06 | 4,834 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2023-01-05 | 2023-01-06 | 22,655 | $113.24 | $2.57M | 42,907 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2023-01-05 | 2023-01-06 | 51,132 | — | $0 | 65,562 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2023-01-04 | 2023-01-06 | 18,397 | — | $0 | 18,397 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2023-01-01 | 2023-01-04 | 21,772 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2023-01-01 | 2023-01-04 | 9,717 | $113.80 | $1.11M | 14,430 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2023-01-01 | 2023-01-04 | 21,772 | — | $0 | 24,147 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2022-12-27 | 2022-12-29 | 13,972 | — | $0 | 13,972 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2022-12-27 | 2022-12-29 | 21,772 | — | $0 | 21,772 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2022-12-12 | 2022-12-13 | 21,378 | $111.45 | $2.38M | 84,430 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2022-12-12 | 2022-12-13 | 6,974 | $111.44 | $777.2K | 54,501 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2022-06-08 | 2022-06-09 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2022-06-08 | 2022-06-09 | 15,000 | — | $0 | 65,378 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2022-05-27 | 2022-12-13 | 8,531 | — | $0 | 2,375 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2022-05-27 | 2022-12-13 | 8,531 | — | $0 | 61,475 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2022-04-06 | 2022-04-08 | 42,009 | $110.02 | $4.62M | 10,629 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-03-18 | 2022-03-21 | 8,531 | — | $0 | 164,469 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2022-03-18 | 2022-03-21 | 8,531 | $22.14 | $188.9K | 52,638 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2022-03-10 | 2022-03-21 | 8,169 | — | $0 | 44,107 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2022-03-10 | 2022-03-21 | 8,169 | — | $0 | 52,944 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-01-21 | 2022-01-24 | 5,354 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2022-01-21 | 2022-01-24 | 5,354 | — | $0 | 61,665 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2022-01-21 | 2022-01-24 | 2,372 | $86.42 | $205.0K | 59,293 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-01-05 | 2022-01-06 | 9,314 | — | $0 | 18,628 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-01-05 | 2022-01-06 | 9,678 | — | $0 | 4,834 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-01-05 | 2022-01-06 | 9,222 | — | $0 | 9,223 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-01-05 | 2022-01-06 | 12,095 | — | $0 | 12,095 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-01-05 | 2022-01-06 | 12,261 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2022-01-05 | 2022-01-06 | 37,675 | — | $0 | 56,311 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2022-01-05 | 2022-01-06 | 52,570 | — | $0 | 61,685 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award | 2022-01-05 | 2022-01-06 | 32,301 | — | $0 | 93,986 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2022-01-04 | 2022-01-06 | 19,044 | — | $0 | 19,044 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2021-12-13 | 2022-01-06 | 50 | — | $0 | 37,758 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2021-11-08 | 2022-01-06 | 10,729 | — | $0 | 37,808 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2021-11-08 | 2022-01-06 | 10,729 | — | $0 | 9,115 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-10-27 | 2021-10-29 | 10,729 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2021-10-27 | 2021-10-29 | 10,729 | $7.61 | $81.6K | 19,844 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 11,228 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 19,650 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 20,000 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 11,228 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 47,040 | — | $0 | 47,040 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 31,360 | — | $0 | 31,360 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 31,360 | — | $0 | 31,360 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 19,650 | — | $0 | 19,650 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 11,228 | — | $0 | 11,228 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 11,228 | — | $0 | 11,228 | SEC↗ |
| SBBP Strongbridge Biopharma plc | D To issuer deriv | 2021-10-05 | 2021-10-06 | 140,000 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2021-10-05 | 2021-10-05 | 50,378 | — | $0 | 50,378 | SEC↗ |
| SBBP Strongbridge Biopharma plc | D To issuer | 2021-10-05 | 2021-10-06 | 64,258 | — | $0 | 0 | SEC↗ |
| SBBP Strongbridge Biopharma plc | F Tax w/h | 2021-10-01 | 2021-10-05 | 17,763 | $2.06 | $36.6K | 64,258 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-09-21 | 2021-09-23 | 46,271 | — | $0 | 10,729 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2021-09-21 | 2021-09-23 | 46,271 | $7.61 | $352.1K | 55,386 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2021-09-21 | 2021-09-23 | 46,271 | $110.00 | $5.09M | 9,115 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2021-09-03 | 2021-09-23 | 4,042 | — | $0 | 9,115 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2021-09-03 | 2021-09-23 | 4,042 | — | $0 | 27,079 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2021-07-28 | 2021-07-30 | 14,514 | — | $0 | 14,514 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2021-07-28 | 2021-07-30 | 3,215 | $102.50 | $329.5K | 13,157 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award | 2021-07-28 | 2021-07-30 | 7,257 | — | $0 | 16,372 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2021-07-01 | 2021-07-02 | 5,287 | $95.00 | $502.3K | 9,115 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2021-07-01 | 2021-07-02 | 54,789 | $95.00 | $5.20M | 128,845 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2021-06-11 | 2022-03-21 | 5,287 | — | $0 | 44,775 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2021-06-11 | 2022-03-21 | 5,287 | — | $0 | 52,276 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award deriv | 2021-06-08 | 2021-06-08 | 11,228 | — | $0 | 11,228 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2021-05-25 | 2022-03-21 | 12,304 | — | $0 | 50,062 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2021-05-25 | 2022-03-21 | 12,304 | — | $0 | 46,989 | SEC↗ |
| SBBP Strongbridge Biopharma plc | A Award | 2021-05-18 | 2021-05-18 | 40,000 | — | $0 | 82,021 | SEC↗ |
| SBBP Strongbridge Biopharma plc | F Tax w/h | 2021-05-14 | 2021-05-17 | 18,944 | $2.35 | $44.5K | 42,021 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2021-03-10 | 2021-07-02 | 66,730 | — | $0 | 14,402 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2021-03-10 | 2021-07-02 | 66,730 | — | $0 | 66,730 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2021-02-17 | 2021-02-19 | 14,512 | — | $0 | 14,512 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2021-02-17 | 2021-02-19 | 3,931 | — | $0 | 3,931 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2021-02-17 | 2021-02-19 | 871 | $87.17 | $75.9K | 80,083 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award | 2021-02-17 | 2021-02-19 | 1,965 | — | $0 | 80,954 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-01-21 | 2021-01-22 | 5,353 | — | $0 | 5,354 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2021-01-21 | 2021-01-22 | 5,353 | — | $0 | 81,361 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2021-01-21 | 2021-01-22 | 2,372 | $77.43 | $183.7K | 78,989 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-01-05 | 2021-01-06 | 12,094 | — | $0 | 24,190 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-01-05 | 2021-01-06 | 17,260 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-01-05 | 2021-01-06 | 12,261 | — | $0 | 12,261 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2021-01-05 | 2021-01-06 | 41,615 | — | $0 | 69,630 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2021-01-05 | 2021-01-06 | 45,256 | $73.28 | $3.32M | 84,687 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award | 2021-01-05 | 2021-01-06 | 60,313 | — | $0 | 129,943 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2021-01-04 | 2021-01-06 | 27,942 | — | $0 | 27,942 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2020-12-29 | 2021-01-22 | 8,679 | — | $0 | 183,634 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2020-12-29 | 2021-01-22 | 8,679 | — | $0 | 76,008 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2020-12-08 | 2020-12-09 | 9,631 | $70.60 | $679.9K | 206,088 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2020-12-08 | 2020-12-09 | 31,133 | $71.32 | $2.22M | 174,955 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2020-12-07 | 2020-12-09 | 10,489 | $72.24 | $757.7K | 215,719 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2020-12-07 | 2020-12-09 | 16,200 | $71.52 | $1.16M | 226,208 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2020-12-07 | 2020-12-09 | 36,389 | $70.31 | $2.56M | 242,408 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2020-10-21 | 2020-10-21 | 13,000 | — | $0 | 57,000 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2020-10-21 | 2020-10-22 | 13,000 | — | $0 | 57,000 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2020-10-21 | 2020-10-21 | 13,000 | $7.61 | $98.9K | 28,015 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2020-10-21 | 2020-10-22 | 13,000 | $7.61 | $98.9K | 28,015 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2020-07-06 | 2020-07-07 | 9,100 | $57.50 | $523.3K | 278,797 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award deriv | 2020-06-04 | 2020-06-04 | 11,228 | — | $0 | 11,228 | SEC↗ |
| SBBP Strongbridge Biopharma plc | F Tax w/h | 2020-05-15 | 2020-05-18 | 19,035 | $2.86 | $54.4K | 60,965 | SEC↗ |
| SBBP Strongbridge Biopharma plc | A Award | 2020-05-14 | 2020-05-15 | 40,000 | — | $0 | 80,000 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2020-05-11 | 2020-05-12 | 33,479 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2020-05-11 | 2020-05-12 | 33,479 | $45.00 | $1.51M | 13,966 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2020-05-11 | 2020-05-12 | 33,479 | $4.96 | $166.1K | 47,445 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2020-03-11 | 2020-03-13 | 5,287 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2020-03-11 | 2020-03-13 | 5,287 | $12.94 | $68.4K | 13,966 | SEC↗ |
| SBBP Strongbridge Biopharma plc | A Award | 2019-05-15 | 2019-05-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award deriv | 2019-02-27 | 2019-03-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SBBP Strongbridge Biopharma plc | A Award deriv | 2018-05-15 | 2018-05-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2018-03-23 | 2018-03-27 | 19,250 | — | $0 | 19,250 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2018-03-23 | 2018-03-27 | 19,250 | — | $0 | 220,869 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2018-03-23 | 2018-03-27 | 8,528 | $13.86 | $118.2K | 212,341 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2018-01-02 | 2018-01-03 | 15,500 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2018-01-02 | 2018-01-03 | 7,680 | $15.02 | $115.4K | 201,619 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2018-01-02 | 2018-01-03 | 15,500 | — | $0 | 209,299 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2017-03-23 | 2017-03-24 | 19,250 | — | $0 | 38,500 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2017-03-23 | 2017-03-24 | 19,250 | — | $0 | 201,148 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2017-03-23 | 2017-03-24 | 8,798 | $14.56 | $128.1K | 192,350 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2017-01-02 | 2017-01-04 | 15,500 | — | $0 | 15,500 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2017-01-02 | 2017-01-04 | 11,250 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2017-01-02 | 2017-01-04 | 26,750 | — | $0 | 194,500 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2017-01-02 | 2017-01-04 | 12,602 | $16.18 | $203.9K | 181,898 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2016-12-16 | 2016-12-19 | 8,500 | — | $0 | 5,313 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2016-12-16 | 2016-12-19 | 8,500 | $2.40 | $20.4K | 167,750 | SEC↗ |
| HZNP Horizon Pharma plc | S Sale | 2016-08-02 | 2016-08-02 | 2,900 | $20.00 | $58.0K | 159,250 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2016-03-23 | 2016-03-24 | 19,250 | — | $0 | 57,750 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2016-03-23 | 2016-03-24 | 8,798 | $16.32 | $143.6K | 160,100 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2016-03-23 | 2016-03-24 | 19,250 | — | $0 | 168,898 | SEC↗ |
| HZNP Horizon Pharma plc | S Sale | 2016-02-26 | 2016-02-29 | 4,100 | $20.00 | $82.0K | 149,648 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2016-01-02 | 2016-01-05 | 15,500 | — | $0 | 31,000 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2016-01-02 | 2016-01-05 | 11,250 | — | $0 | 11,250 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2016-01-02 | 2016-01-05 | 26,750 | — | $0 | 162,324 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2016-01-02 | 2016-01-05 | 8,576 | $21.67 | $185.8K | 153,748 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2015-12-15 | 2015-12-16 | 17,692 | — | $0 | 33,479 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2015-12-15 | 2015-12-16 | 12,750 | — | $0 | 13,813 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2015-12-15 | 2015-12-16 | 17,692 | $4.96 | $87.8K | 135,574 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2015-12-15 | 2015-12-16 | 12,750 | $2.40 | $30.6K | 117,882 | SEC↗ |
| HZNP Horizon Pharma plc | S Sale | 2015-12-10 | 2015-12-10 | 4,456 | $20.00 | $89.1K | 105,132 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2015-12-08 | 2015-12-09 | 8,208 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2015-12-08 | 2015-12-10 | 8,208 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2015-12-08 | 2015-12-09 | 3,752 | $21.40 | $80.3K | 109,588 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2015-12-08 | 2015-12-09 | 8,208 | — | $0 | 113,340 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2015-12-08 | 2015-12-10 | 8,208 | — | $0 | 113,340 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2015-12-08 | 2015-12-10 | 3,752 | $20.40 | $76.5K | 109,588 | SEC↗ |
| HZNP Horizon Pharma plc | S Sale | 2015-09-21 | 2015-09-21 | 7,750 | $31.78 | $246.3K | 105,132 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2015-07-15 | 2015-07-17 | 2,450 | — | $0 | 51,171 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2015-07-15 | 2015-07-17 | 24,437 | — | $0 | 26,563 | SEC↗ |
| HZNP Horizon Pharma plc | S Sale | 2015-07-15 | 2015-07-17 | 2,450 | $35.55 | $87.1K | 112,882 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2015-07-15 | 2015-07-17 | 24,437 | $2.40 | $58.6K | 137,319 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2015-07-15 | 2015-07-17 | 2,450 | $4.96 | $12.2K | 115,332 | SEC↗ |
| HZNP Horizon Pharma plc | S Sale | 2015-07-15 | 2015-07-17 | 24,437 | $35.55 | $868.7K | 112,882 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2015-05-06 | 2015-05-08 | 558,000 | — | $0 | 558,000 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2015-03-23 | 2015-03-25 | 173,000 | — | $0 | 173,000 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2015-03-23 | 2015-03-25 | 77,000 | — | $0 | 77,000 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2015-03-23 | 2015-03-25 | 186,000 | — | $0 | 186,000 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2015-01-02 | 2015-01-06 | 11,250 | — | $0 | 22,500 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2015-01-02 | 2015-01-06 | 15,500 | — | $0 | 46,500 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2015-01-02 | 2015-01-06 | 26,750 | — | $0 | 111,086 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2015-01-02 | 2015-01-06 | 8,753 | $12.80 | $112.0K | 102,333 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2014-12-08 | 2015-01-26 | 8,208 | — | $0 | 8,208 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2014-12-08 | 2015-01-26 | 2,656 | $12.99 | $34.5K | 84,336 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2014-12-08 | 2015-01-26 | 8,208 | — | $0 | 86,992 | SEC↗ |
| HZNP Horizon Pharma plc | S Sale | 2014-11-19 | 2014-11-20 | 24,999 | $12.05 | $301.2K | 74,299 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 46,335 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 62,000 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 47,654 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 42,295 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 53,621 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 16,416 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 51,000 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 33,750 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 70,000 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 53,621 | — | $0 | 53,621 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 51,000 | — | $0 | 51,000 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 33,750 | — | $0 | 33,750 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 70,000 | — | $0 | 70,000 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 62,000 | — | $0 | 62,000 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 46,335 | — | $0 | 46,335 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 47,654 | — | $0 | 47,654 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 42,295 | — | $0 | 42,295 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 16,416 | — | $0 | 16,416 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer | 2014-09-19 | 2014-09-22 | 99,298 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | A Award | 2014-09-19 | 2014-09-22 | 99,298 | — | $0 | 99,298 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | S Sale | 2014-05-19 | 2014-05-21 | 9,361 | $12.94 | $121.1K | 93,235 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2014-01-02 | 2015-01-26 | 11,250 | — | $0 | 33,750 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2014-01-02 | 2015-01-26 | 11,250 | — | $0 | 102,596 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | A Award deriv | 2014-01-02 | 2014-01-10 | 62,000 | — | $0 | 62,000 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | A Award deriv | 2014-01-02 | 2014-01-10 | 70,000 | — | $0 | 70,000 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | M Exercise deriv | 2013-12-09 | 2013-12-09 | 8,208 | — | $0 | 16,416 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | M Exercise | 2013-12-09 | 2013-12-09 | 8,208 | — | $0 | 91,346 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | A Award | 2013-12-05 | 2013-12-09 | 18,037 | — | $0 | 83,138 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | A Award deriv | 2013-01-02 | 2013-01-03 | 51,000 | — | $0 | 51,000 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | A Award deriv | 2013-01-02 | 2013-01-03 | 45,000 | — | $0 | 45,000 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | S Sale | 2013-01-02 | 2013-01-03 | 16,304 | $2.36 | $38.5K | 55,099 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | M Exercise deriv | 2012-12-10 | 2012-12-12 | 8,208 | — | $0 | 24,624 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | M Exercise | 2012-12-10 | 2012-12-12 | 8,208 | — | $0 | 71,403 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | A Award | 2012-07-26 | 2012-07-27 | 33,000 | — | $0 | 61,105 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | A Award | 2012-03-02 | 2012-03-07 | 22,000 | — | $0 | 22,000 | SEC↗ |